Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation

Cell Reports

Volumn 9, Issue 1, 2014, Pages 261-271

  Alder, Olivia ^a   Cullum, Rebecca ^a   Lee, Sam ^a   Kan, Arohumam C ^a   Wei, Wei ^a   Yi, Yuyin ^a   Garside, Victoria C ^a   Bilenky, Misha ^a   Griffith, Malachi ^a   Morrissy, A Sorana ^a   Robertson, Gordon A ^a   Thiessen, Nina ^a   Zhao, Yongjun ^a   Chen, Qian ^b   Pan, Duojia ^b   Jones, Steven J M ^a,c,d   Marra, Marco A ^a,d   Hoodless, Pamela A ^a,d  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MEMBRANE PROTEIN; PROTEIN HIPPO; PROTEIN TEAD2; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG; FOXA2 PROTEIN, MOUSE; HEPATOCYTE NUCLEAR FACTOR 4; HIPPO PROTEIN, MOUSE; HNF4A PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENE TARGETING; IN VIVO STUDY; LIVER CELL; LIVER DEVELOPMENT; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84907996370     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.046     Document Type: Article

References (52)

1. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 2000, 25:25-29. The Gene Ontology Consortium.
2. Battle M.A., Konopka G., Parviz F., Gaggl A.L., Yang C., Sladek F.M., Duncan S.A. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc. Natl. Acad. Sci. USA 2006, 103:8419-8424.
3. Blankenberg D., Von Kuster G., Coraor N., Ananda G., Lazarus R., Mangan M., Nekrutenko A., Taylor J. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. 2010, Chapter 19. Unit 19.10.1-2.
4. Bochkis I.M., Schug J., Rubins N.E., Chopra A.R., O'Malley B.W., Kaestner K.H. Foxa2-dependent hepatic gene regulatory networks depend on physiological state. Physiol. Genomics 2009, 38:186-195.
5. Buecker C., Srinivasan R., Wu Z., Calo E., Acampora D., Faial T., Simeone A., Tan M., Swigut T., Wysocka J. Reorganization of enhancer patterns in transition from naive to primed pluripotency. Cell Stem Cell 2014, 14:838-853.
6. Camargo F.D., Gokhale S., Johnnidis J.B., Fu D., Bell G.W., Jaenisch R., Brummelkamp T.R. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 2007, 17:2054-2060.
7. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
8. Du Y., Wang J., Jia J., Song N., Xiang C., Xu J., Hou Z., Su X., Liu B., Jiang T., et al. Human hepatocytes with drug metabolic function induced fromfibroblasts by lineage reprogramming. Cell Stem Cell 2014, 14:394-403.
9. Duncan S.A., Nagy A., Chan W. Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(-/-) embryos. Development 1997, 124:279-287.
10. Eden E., Navon R., Steinfeld I., Lipson D., Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 2009, 10:48.
11. Fejes A.P., Robertson G., Bilenky M., Varhol R., Bainbridge M., Jones S.J. FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology. Bioinformatics 2008, 24:1729-1730.
12. Godbout R., Ingram R.S., Tilghman S.M. Fine-structure mapping of the three mouse alpha-fetoprotein gene enhancers. Mol. Cell. Biol. 1988, 8:1169-1178.
13. Goecks J., Nekrutenko A., Taylor J. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 2010, 11:R86. Galaxy Team.
14. Griffith M., Griffith O.L., Mwenifumbo J., Goya R., Morrissy A.S., Morin R.D., Corbett R., Tang M.J., Hou Y.C., Pugh T.J., et al. Alternative expression analysis by RNA sequencing. Nat. Methods 2010, 7:843-847.
15. Grozdanov P.N., Yovchev M.I., Dabeva M.D. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab. Invest. 2006, 86:1272-1284.
16. Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., Gonzalez F.J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 2001, 21:1393-1403.
17. He H.H., Meyer C.A., Shin H., Bailey S.T., Wei G., Wang Q., Zhang Y., Xu K., Ni M., Lupien M., et al. Nucleosome dynamics define transcriptional enhancers. Nat. Genet. 2010, 42:343-347.
18. Heallen T., Zhang M., Wang J., Bonilla-Claudio M., Klysik E., Johnson R.L., Martin J.F. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
19. Hoffman B.G., Robertson G., Zavaglia B., Beach M., Cullum R., Lee S., Soukhatcheva G., Li L., Wederell E.D., Thiessen N., et al. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res. 2010, 20:1037-1051.
20. Hong Y.H., Varanasi U.S., Yang W., Leff T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J.Biol. Chem. 2003, 278:27495-27501.
21. Huang P., He Z., Ji S., Sun H., Xiang D., Liu C., Hu Y., Wang X., Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts bydefined factors. Nature 2011, 475:386-389.
22. Huang P., Zhang L., Gao Y., He Z., Yao D., Wu Z., Cen J., Chen X., Liu C., Hu Y., et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 2014, 14:370-384.
23. Kyrmizi I., Hatzis P., Katrakili N., Tronche F., Gonzalez F.J., Talianidis I. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 2006, 20:2293-2305.
24. Labbé E., Silvestri C., Hoodless P.A., Wrana J.L., Attisano L. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 1998, 2:109-120.
25. Lee C.S., Friedman J.R., Fulmer J.T., Kaestner K.H. The initiation of liver development is dependent on Foxa transcription factors. Nature 2005, 435:944-947.
26. Li Z., Tuteja G., Schug J., Kaestner K.H. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell 2012, 148:72-83.
27. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
28. Oikawa T., Kamiya A., Kakinuma S., Zeniya M., Nishinakamura R., Tajiri H., Nakauchi H. Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. Gastroenterology 2009, 136:1000-1011.
29. Ong C.T., Corces V.G. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 2011, 12:283-293.
30. Parviz F., Matullo C., Garrison W.D., Savatski L., Adamson J.W., Ning G., Kaestner K.H., Rossi J.M., Zaret K.S., Duncan S.A. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 2003, 34:292-296.
31. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
32. Raju R., Chau D., Verfaillie C.M., Hu W.S. The road to regenerative liver therapies: the triumphs, trials and tribulations. Biotechnol. Adv. 2013, 31:1085-1093.
33. Robertson G., Hirst M., Bainbridge M., Bilenky M., Zhao Y., Zeng T., Euskirchen G., Bernier B., Varhol R., Delaney A., et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 2007, 4:651-657.
34. Schlegelmilch K., Mohseni M., Kirak O., Pruszak J., Rodriguez J.R., Zhou D., Kreger B.T., Vasioukhin V., Avruch J., Brummelkamp T.R., Camargo F.D. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 2011, 144:782-795.
35. Sekiya S., Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475:390-393.
36. Sekiya T., Muthurajan U.M., Luger K., Tulin A.V., Zaret K.S. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev. 2009, 23:804-809.
37. Septer S., Edwards G., Gunewardena S., Wolfe A., Li H., Daniel J., Apte U. Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G493-G503.
38. Shen Y., Yue F., McCleary D.F., Ye Z., Edsall L., Kuan S., Wagner U., Dixon J., Lee L., Lobanenkov V.V., Ren B. A map of the cis-regulatory sequences in the mouse genome. Nature 2012, 488:116-120.
39. Shin H., Liu T., Manrai A.K., Liu X.S. CEAS: cis-regulatory element annotation system. Bioinformatics 2009, 25:2605-2606.
40. Simeonov K.P., Uppal H. Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. PLoS ONE 2014, 9:e100134.
41. Soleimani V.D., Yin H., Jahani-Asl A., Ming H., Kockx C.E., van Ijcken W.F., Grosveld F., Rudnicki M.A. Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis. Mol. Cell 2012, 47:457-468.
42. Subramanian K., Owens D.J., Raju R., Firpo M., O'Brien T.D., Verfaillie C.M., Hu W.S. Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells. Stem Cells Dev. 2014, 23:124-131.
43. Tanimizu N., Nishikawa M., Saito H., Tsujimura T., Miyajima A. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J.Cell Sci. 2003, 116:1775-1786.
44. Tennant B.R., Robertson A.G., Kramer M., Li L., Zhang X., Beach M., Thiessen N., Chiu R., Mungall K., Whiting C.J., et al. Identification and analysis of murine pancreatic islet enhancers. Diabetologia 2013, 56:542-552.
45. Torres-Padilla M.E., Fougère-Deschatrette C., Weiss M.C. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing. Mech. Dev. 2001, 109:183-193.
46. Wederell E.D., Bilenky M., Cullum R., Thiessen N., Dagpinar M., Delaney A., Varhol R., Zhao Y., Zeng T., Bernier B., et al. Global analysis of invivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing. Nucleic Acids Res. 2008, 36:4549-4564.
47. Wei W., Hou J., Alder O., Ye X., Lee S., Cullum R., Chu A., Zhao Y., Warner S.M., Knight D.A., et al. Genome-wide microRNA and messenger RNA profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling. Hepatology 2013, 57:2491-2501.
48. Yimlamai D., Christodoulou C., Galli G.G., Yanger K., Pepe-Mooney B., Gurung B., Shrestha K., Cahan P., Stanger B.Z., Camargo F.D. Hippo pathway activity influences liver cell fate. Cell 2014, 157:1324-1338.
49. Yong K.J., Gao C., Lim J.S., Yan B., Yang H., Dimitrov T., Kawasaki A., Ong C.W., Wong K.F., Lee S., et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N.Engl. J. Med. 2013, 368:2266-2276.
50. Yu F.X., Guan K.L. The Hippo pathway: regulators and regulations. Genes Dev. 2013, 27:355-371.
51. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
52. Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.T., Luk J.M., Wigler M., Hannon G.J., et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125:1253-1267.